Related Experiment Video
Updated: Feb 3, 2026

Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
Untangling the Role of Polycomb Complexes in Chemotherapy Resistance
Cihangir Duy1, Ari Melnick1,2
1Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, New York. amm2014@med.cornell.edu cid2001@med.cornell.edu.
Abstract:
In this issue, Maganti and colleagues described an epigenetic link between reduced abundance of Polycomb-related protein MTF2 and chemotherapy resistance in refractory acute myeloid leukemia. MTF2 deficiency impaired expression of the PRC2 complex and deposition of H3K27me3 at many genes, including the key target gene
Insights
Reduced abundance of the Polycomb-related protein MTF2 is linked to chemotherapy resistance in acute myeloid leukemia. MTF2 deficiency affects key gene expression and epigenetic modifications, impacting treatment outcomes.
Area of Science:
- Hematology
- Epigenetics
- Cancer Biology
Background:
- Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy.
- Chemotherapy resistance remains a significant challenge in treating refractory AML.
- Epigenetic dysregulation plays a crucial role in cancer development and treatment response.
Purpose of the Study:
- To investigate the role of Polycomb-related protein MTF2 in chemotherapy resistance in refractory AML.
- To elucidate the epigenetic mechanisms underlying MTF2's function in AML.
Main Methods:
- Analysis of MTF2 protein abundance in refractory AML patient samples.
- Assessment of Polycomb Repressive Complex 2 (PRC2) activity and H3K27me3 deposition.
- Gene expression profiling to identify MTF2 targets.
Main Results:
- Reduced abundance of MTF2 was observed in refractory AML.
- MTF2 deficiency led to impaired expression of the PRC2 complex.
- Decreased deposition of H3K27me3 was noted at numerous genes, including critical target genes.
Conclusions:
- MTF2 is epigenetically linked to chemotherapy resistance in refractory AML.
- MTF2 deficiency disrupts PRC2 function and H3K27me3 modification, contributing to treatment failure.
- Targeting MTF2 or its downstream pathways may offer novel therapeutic strategies for AML.
Related Concept Videos
Resistivity
Resistance
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
Role of Septins
Cellular Functions of Septins
Recent studies have revealed the multifaceted roles of septins in various cellular processes such as cytokinesis, ciliogenesis, and neurogenesis. Septins act as scaffolds and...

